Variant report
Variant | nsv1025747 |
---|---|
Chromosome Location | chr7:15017847-15045637 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:67)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr7:15035586-15035785 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CEBPB | chr7:15040679-15040860 | HepG2 | liver: | n/a | chr7:15040775-15040786 chr7:15040775-15040788 |
3 | CTCF | chr7:15035520-15035670 | BE2_C | brain: | n/a | n/a |
4 | CTCF | chr7:15028940-15029090 | BE2_C | brain: | n/a | n/a |
5 | CTCF | chr7:15043609-15043665 | GM10248 | blood: | n/a | n/a |
6 | CTCF | chr7:15028920-15029070 | BE2_C | brain: | n/a | n/a |
7 | CTCF | chr7:15028840-15028990 | SK-N-SH_RA | brain: | n/a | n/a |
8 | CTCF | chr7:15028360-15028510 | HRE | kidney: | n/a | n/a |
9 | EP300 | chr7:15028526-15028996 | SK-N-SH_RA | brain: | n/a | n/a |
10 | EP300 | chr7:15028582-15029024 | SK-N-SH_RA | brain: | n/a | n/a |
11 | FOS | chr7:15039337-15039650 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | FOS | chr7:15039363-15039668 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | FOS | chr7:15039103-15039642 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | FOS | chr7:15018279-15018900 | HUVEC | blood vessel: | n/a | n/a |
15 | FOS | chr7:15039079-15039147 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | FOXA1 | chr7:15039796-15040146 | HepG2 | liver: | n/a | n/a |
17 | FOXA1 | chr7:15039863-15040138 | HepG2 | liver: | n/a | n/a |
18 | FOXA2 | chr7:15039841-15040138 | HepG2 | liver: | n/a | n/a |
19 | GATA2 | chr7:15028382-15029187 | SH-SY5Y | brain: | n/a | n/a |
20 | GATA2 | chr7:15018249-15018778 | HUVEC | blood vessel: | n/a | chr7:15018550-15018561 |
21 | GATA3 | chr7:15031449-15031468 | SH-SY5Y | brain: | n/a | n/a |
22 | GATA3 | chr7:15028861-15028862 | SH-SY5Y | brain: | n/a | n/a |
23 | GATA3 | chr7:15028517-15029125 | SK-N-SH | brain: | n/a | n/a |
24 | HNF4A | chr7:15039845-15040126 | HepG2 | liver: | n/a | n/a |
25 | JUN | chr7:15037860-15037904 | HepG2 | liver: | n/a | chr7:15037870-15037883 chr7:15037874-15037883 |
26 | JUND | chr7:15037783-15037958 | HepG2 | liver: | n/a | chr7:15037874-15037883 |
27 | JUND | chr7:15020570-15020733 | HepG2 | liver: | n/a | n/a |
28 | JUND | chr7:15039527-15039765 | HepG2 | liver: | n/a | n/a |
29 | MAFF | chr7:15045323-15045668 | HepG2 | liver: | n/a | n/a |
30 | MAFF | chr7:15035490-15035824 | HepG2 | liver: | n/a | chr7:15035638-15035656 |
31 | MAFF | chr7:15045375-15045605 | K562 | blood: | n/a | n/a |
32 | MAFK | chr7:15045315-15045644 | HepG2 | liver: | n/a | chr7:15045498-15045509 chr7:15045498-15045509 chr7:15045489-15045506 |
33 | MAFK | chr7:15045314-15045683 | HepG2 | liver: | n/a | chr7:15045498-15045509 chr7:15045498-15045509 chr7:15045489-15045506 |
34 | MAFK | chr7:15035500-15035833 | IMR90 | lung: | n/a | n/a |
35 | MAFK | chr7:15032322-15032554 | HepG2 | liver: | n/a | n/a |
36 | MAFK | chr7:15035494-15035815 | H1-hESC | embryonic stem cell: | n/a | n/a |
37 | MAFK | chr7:15035502-15035801 | HepG2 | liver: | n/a | n/a |
38 | MAFK | chr7:15045313-15045680 | IMR90 | lung: | n/a | chr7:15045498-15045509 chr7:15045498-15045509 chr7:15045489-15045506 |
39 | MAFK | chr7:15024172-15024238 | HepG2 | liver: | n/a | chr7:15024206-15024221 |
40 | MAFK | chr7:15029497-15029686 | HepG2 | liver: | n/a | n/a |
41 | MAX | chr7:15039029-15039855 | NB4 | blood: | n/a | chr7:15039291-15039301 |
42 | MAZ | chr7:15039244-15039341 | Hela-S3 | cervix: | n/a | n/a |
43 | MYC | chr7:15038851-15039362 | NB4 | blood: | n/a | chr7:15039291-15039301 |
44 | POLR2A | chr7:15035985-15036008 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | POLR2A | chr7:15040332-15040580 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | POLR2A | chr7:15028583-15028959 | SK-N-SH | brain: | n/a | n/a |
47 | POLR2A | chr7:15034394-15034594 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | POLR2A | chr7:15044396-15044497 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | POLR2A | chr7:15032948-15032968 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | POLR2A | chr7:15020095-15020133 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DGKB-1 | chr7:15025003-15025699 | NONHSAT119271 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000225816 | TF binding region |
DGKB | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542142490 | chr7:15017848-15017849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561891963 | chr7:15017939-15017940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527466972 | chr7:15017980-15017981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547530107 | chr7:15017984-15017985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142212305 | chr7:15018028-15018029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs373787233 | chr7:15018033-15018034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532942417 | chr7:15018068-15018069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377485145 | chr7:15018104-15018105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187593448 | chr7:15018106-15018107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113892815 | chr7:15018148-15018149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569620924 | chr7:15018157-15018158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139512273 | chr7:15018190-15018191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190774582 | chr7:15018193-15018194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs79117923 | chr7:15018200-15018201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs76163175 | chr7:15018246-15018247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534101101 | chr7:15018248-15018249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537012363 | chr7:15018253-15018254 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs73290630 | chr7:15018266-15018267 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs181056785 | chr7:15018272-15018273 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs73060878 | chr7:15018293-15018294 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs113475290 | chr7:15018300-15018301 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs542179149 | chr7:15018302-15018303 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs186194015 | chr7:15018308-15018309 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs190257817 | chr7:15018322-15018323 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs191953872 | chr7:15018338-15018339 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs556363485 | chr7:15018349-15018350 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs556993945 | chr7:15018371-15018372 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs532922815 | chr7:15018447-15018448 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs144176802 | chr7:15018448-15018449 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs562980636 | chr7:15018476-15018477 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs375534800 | chr7:15018487-15018488 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs112542529 | chr7:15018512-15018513 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs546114170 | chr7:15018547-15018548 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs548495474 | chr7:15018550-15018551 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs368218651 | chr7:15018565-15018566 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs574566178 | chr7:15018577-15018578 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs146550057 | chr7:15018607-15018608 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs569879040 | chr7:15018694-15018695 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs527890484 | chr7:15018757-15018758 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs575276296 | chr7:15018768-15018769 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs77560672 | chr7:15018778-15018779 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs58555005 | chr7:15018789-15018790 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs58257515 | chr7:15018790-15018791 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs539578502 | chr7:15018794-15018795 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs556603382 | chr7:15018815-15018816 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs75286542 | chr7:15018837-15018838 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs62448586 | chr7:15018855-15018856 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs555638114 | chr7:15018857-15018858 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs112661086 | chr7:15018914-15018915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112334886 | chr7:15018933-15018934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:15017600-15019800 | Enhancers | HUVEC | blood vessel |
2 | chr7:15039000-15040600 | Enhancers | Liver | Liver |
3 | chr7:15039600-15040000 | Enhancers | HepG2 | liver |